钠原子激光增强电离光谱研究—以石墨杯为原子化器 原子吸收光谱法对发样中Zn、Cu、Mn、Ap的测定

、I钠原子激光增强电离光谱(LEIS)方法的研究-以石墨杯为原子化器在LEIS方法中，最常见的原子化器是火焰。但由于火焰背景噪声严重且难以克服，在火焰原子化过程中，雾化和热离解不充分，仅有10~(-2)%的分析溶液参与吸收以及火焰气体使测定元素受到高度稀释等不利因素的影响，火焰原子化限制了LEIS方法灵敏度的进一步提高。考虑到石墨炉原子化器较火焰具有取样量少，绝对灵敏度高；样品（包括固态、液态）可直接引入石墨炉内；不会发生如同火焰中所存在的干扰效应；蒸发效率和原子化效率较高，几乎全部样品都能参与吸收等优点，本工作在已建立火焰LEIS方法的实验基础上，将原子化器改换为石墨杯进行了钠原子LEIS方法的研究。到目前为止，国内外仅有的几篇有关石黑炉LEIS的研究报告中，都报导了该方法对钠原子的检出限估计可达到10~(-14)-10~(-15)克，由于此项研究尚处于探索性研究阶段，故有关方法性的系统研究几乎还未见报导。本工作在未使用任何放大器的情况下（实验条件限制）对影响钠原子LEIS信号强度的诸因互进行了实验观察。主要包括：钠原子化条件；激光束位置、阳极电压、激光输出能量、电极位置以及激光脉冲重复率对LEIS信号强度的影响等。并绘制了校准曲线，统计方法的相对标准偏差分别为11%（高浓度）18.2%（低浓度），在现有仪器条件下，还不能测出检出限，测定下限为3*10~(-9)克。对固体粉末直接进行了尝试，检测下限为5*10~(-8)克，进样是为5毫克。在进一步的研究工作中，如有条件使用低噪声的放大器及Bxear积分器，选择门检时间窗，或采用分步激发等手段，估计本方法定会达到预想的高灵敏度，检敏度至少提高了个数量级。对石墨炉原子化LEIS法来说，似比较详细的研究报告，截至实验停止时还未见报导。II原子吸收光谱法对发样中Zn、Cu、Mn、Al的测定发中微量元素ZN、Cu、Mn均属人体必需元素，与人体的生长发育和多种生理功能，临床医学等方面有着极为密切的关系，而Al则被认为是异致某种疾病的元素之一。本工作报告了用火焰法测定Zn、Cu；石墨炉法测定Al、Mn的结果，其中，对Al的测定，为摆脱基体干扰，加入改进剂Mg(NO_3)_2，并采用平台石墨炉进行试验，得到了线性较好的工作曲线，但在实际测定时，由于实验条件的限制，只能采用一般石墨管加基体改进剂对少娄样品中Al含量进行测定。Zn、Cu、Al三种元素由标准曲线法测定；而Mn由于Fe的干扰无法消除而采用标准加入法测定，并因此限制了测定样品数。Cu、ZN、Mn三种元素的回收率分别为102.8%, 99.7%, 102.5%，变异系数为9.6%, 11.3%, 9.7%，对本地居民发中（30个发样）Zn、Cu含量进行测定，Zn、Cu的含量范围为148-318ppm，7.2-15ppm，并计算了Zn/Cu比。本方法对发样中四种元素的测定结果与ICP法进行对照。两种方法测定结果吻合得较好。

OPTICAL AND STRUCTURAL-PROPERTIES OF AP-MOVPE GAINP/GAAS HETEROSTRUCTURES

Lattice matched GaInP/GaAs heterostructures were grown by atmospheric pressure-metal organic vapor phase epitaxy (AP-MOVPE). Compositional intermixing of As/P and Ga/In near the heterointerfaces was studied by photoluminescence (PL) spectroscopy. Indium segregation, memory effect of In into GaAs and the carry-over of As in the GaInP layer during the growth process were considered as three major factors giving rise to the anomalous emissions in the PL spectra. Both thermal annealing and zinc doping strongly enhanced the compositional interdiffusion near the heterointerfaces.

Software AGROSCRE: apoio à avaliação de tendências de transporte de princípios ativos de agrotóxicos.

AGROSCRE é um programa computacional elaborado em linguagem Quick Basic 4.5, para facilitar a avaliação de princípios ativos de agrotóxicos pelos métodos de GOSS, pelo índice de GUS e por critérios da EPA ? Environmental Protection Agency . O método de GOSS indica o potencial de transporte de princípio ativo associado a sedimento ou dissolvido em água e o método de GUS o potencial de lixiviação dos princípios ativos (p.a.). Os critérios da EPA também avaliam essas tendências de transporte. Para a avaliação de um mesmo princípio ativo pelos 3 modelos são necessárias as seguintes informações dos p.a.: constante de adsorção ao carbono orgânico (Koc), meia vida no solo (t½ solo) , meia vida em água (t½ água), solubilidade em água e constante de Henry (H); sendo que os dados mínimos para rodar pelo menos um dos modelos são Koc e t½ solo. O programa roda em arquivo executável em qualquer computador tipo PC, em ambiente amigável ao usuário.

Manual do usuário do programa AGROSCRE: apoio à avaliação de tendências de transporte de princípios ativos de agrotóxicos.

O programa AGROSCRE foi elaborado para conferir agilidade da avaliação de modelos matemáticos screening, que auxiliam a análise do potencial de contaminação de agrotóxicos em água. Este trabalho apresenta o manual do usuário deste programa, possibilitando uma maior divulgação do uso dos modelos ?screening? e fomentando avaliações, cada vez mais fidedignas, da realidade local do ambiente de produção agrícola nacional, na medida em que os dados de entrada forem refinados. Foi desenvolvido em linguagem Quick Basic 4.5 e necessita de 11K de memória para ser utilizado em modo executável.

Sistema de gerenciamento dos Bancos Ativos de Germoplasma da Embrapa Trigo.

2008

Neuroprotective and immunomodulatory properties of the new PPARγ agonist MDG548: an in vitro and in vivo study in PD models

Neuroinflammation is a key component of Parkinson’s disease (PD) neuropathology. Skewed microglia activation with pro-inflammatory prevailing over anti-inflammatory phenotypes may contribute to neurotoxicity via the production of cytokines and neurotoxic species. Therefore, microglia polarization has been proposed as a target for neuroprotection. The peroxisome proliferator-activated receptor gamma (PPARγ) is expressed in microglia and peripheral immune cells, where it is involved in macrophages polarization and in the control of inflammatory responses, by modulating gene transcription. Several studies have shown that PPARγ agonists are neuroprotective in experimental PD models in rodents and primates. however safety concerns have been raised about PPARγ agonists thiazolidinediones (TZD) currently available, prompting for the development of non-TZD compounds. Aim of this study was to characterize a novel PPARγ agonist non TZD, MDG548, for its potential neuroprotective effect in PD models and its immunomodulatory activity as the underlying mechanism of neuroprotection. The neuroprotective activity of MDG548 was assessed in vivo in the subacute MPTP model and in the chronic MPTP/probenecid (MPTPp) model of PD. MDG548 activity on microglia activation and phenotype was investigated in the substantia nigra pars compacta (SNc) via the evaluation of pro- (TNF-α and iNOS) and anti-inflammatory (CD206) molecules, with fluorescent immunohistochemistry. Moreover, cultured murine microglia MMGT12 were treated with MDG548 in association with the inflammagen LPS, pro- and anti-inflammatory molecules were measured in the medium by ELISA assay and phagocytosis was evaluated by fluorescent immunohistochemistry for CD68. MDG548 arrested dopaminergic cells degeneration in the SNc in both the subacute MPTP and the chronic MPTPp models of PD, and reverted MPTPp-induced motor impairment. Moreover, MDG548 reduced microglia activation, iNOS and TNF-α production, while induced CD206 in microglia. In cultured unstimulated microglia, LPS increased TNF-α production and CD68 expression, while decreased CD206 expression. MDG548 reverted LPS effect on TNF-α and CD206 restoring physiological levels, while strongly increased CD68 expression. Results suggest that the PPARγ agonist MDG548 is neuroprotective in experimental models of PD. MDG548 targets microglia polarization by correcting the imbalance between pro- over antiinflammatory molecules, offering a novel immunomodulatory approach to neuroprotection.

Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

Introduction: Parkinson‟s disease (PD) is characterized by a chronic progressive loss of nigrostriatal dopaminergic neurons that is associated with chronic neuroinflammation. Current treatments for PD can significantly improve symptoms but do not cure the disease or slow its progression. An approach used in existing therapies is based on the inhibition of monoamine oxidase (MAO), enzyme involved in the metabolic degradation of dopamine. Although, preclinical studies showed that MAO-B inhibitors have neuroprotective activity in cellular and animal models of PD, clinical trials did not completely confirm this result. Therefore a large number of new molecules, with more potent MAO-B inhibitory activity and a possible neuroprotective effect, have been proposed to replace the pre-existing MAO-B inhibitors. The profile of the recent MAO inhibitor, SZV558, appears to be particularly interesting because of its pharmacodynamic, favorable for disease-modifying properties and its irreversible MAO-B enzyme bind. The enhancement of adult neurogenesis could be of great clinical interest in the management of neurodegenerative disorders. In line with this, the metformin, a well-known antidiabetic drug, has recently been proposed to promote neurogenesis and to have a neuroprotective effect on the neurodegenerative processes induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in a mice PD model. Although, PD has multiple origins, one hypothesis is that amphetamine-related drugs may be part of the wide array of factors leading to the dopaminergic neuron degeneration that causes the disease. These hypothesis are supported by different results that showed a persistent, long-term dopaminergic toxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in mice. Moreover, the MDMA, altering the dopaminergic transmission, may affect neurogenesis and synaptogenesis. On these basis, considering that the young brain is particularly sensitive to drug-induced neurotoxicity, the consumption of MDMA during the adolescence might increase the vulnerability of dopaminergic neurons. However, the use of amphetamine-related drugs by adolescent and young people is often combined with caffeinated energy drinks in order to amplify their stimulant actions. Although caffeine use is safe, the combined treatment of caffeine and MDMA increases not only the DA release but also the microglia and astroglia activation. Aims: During my Ph.D. I studied the influence of neuroprotective drugs, such as MAO inhibitors and metformin, or substances, such as caffeine, on the neurodegenerative effects of two dopaminergic toxins, MDMA and MPTP, in mice. 1. In the first phase of my study, I evaluated the neuroprotective activity of the new MAO-B inhibitor SZV558, compared with well-known rasagiline, in a chronic mouse model of MPTP plus probenecid (MPTPp), which induces a progressive loss of nigrostriatal dopaminergic neurons. 2. Previous results showed that when MDMA is associated with caffeine, a more pronounced degeneration in adolescent compared with adult mice was observed. To better clarify the molecular mechanism at the base of the different neurotoxic effect of this drug association at different ages, I evaluated the neuronal nitric oxide synthase (nNOS) expression, which plays a critical role in the integration of dopaminergic and glutamatergic transmissions, in the CPu of adolescent or adult mice treated with MDMA, alone or in combination with caffeine. 3. Finally, I investigated the neuroprotective effect of metformin against dopaminergic neurotoxicity induced by MDMA in the CPu and SNc of adult mice. Conclusions: These results demonstrated that the dopaminergic neurodegenerative process may be induced or conditioned by environment stressors or substances which influence, through different ways, the development of neurodegenerative mechanisms. In the present study I evaluated the effects of 3 substances, known as potentially neuroprotective, in combination with two different neurotoxins that affect the nigrostriatal dopaminergic system. The SZV558 MAO-B inhibitor and the metformin protected the nigrostriatal pathway, usually affected in PD, by MPTP- and MDMA- induced neurotoxicity, respectively. On the other hand, caffeine, administrated with MDMA, showed a neurotoxic potential depending on the age of consumers, confirming the vulnerability of adolescent brain to consumption of drug and substances that affected the dopaminergic system. In conclusion, the study of neurodegenerative processes may be relevant to understand the human pharmacology, the origin and development of neurodegenerative disease and to predict the neurotoxic effect of drug abuse.

Gwaith Syr Phylib Emlyn, Syr Lewys Meudwy a Mastr Harri ap Hywel

Bryant-Quinn, M. (2001). Gwaith Syr Phylib Emlyn, Syr Lewys Meudwy a Mastr Harri ap Hywel. Aberystwyth: Canolfan Uwchefrydiau Cymreig a Cheltaidd Prifysgol Cymru.

Gwaith Ieuan ap Llywelyn Fychan, Ieuan Llwyd brydydd a Lewys Aled

Bryant-Quinn, M. (2003). Gwaith Ieuan ap Llywelyn Fychan, Ieuan Llwyd brydydd a Lewys Aled. Aberystwyth: Canolfan Uwchefrydiau Cymreig a Cheltaidd Prifysgol Cymru.

Tudur Aled ai cant yn dda om barn i: Cywydd Cymod Wmffre ap Hywel ap Siancyn o Ynysymaengwyn a'i Geraint

Williams, G. (2007). Tudur Aled ai cant yn dda om barn i: Cywydd Cymod Wmffre ap Hywel ap Siancyn o Ynysymaengwyn a'i Geraint. Ll?n Cymru. 30, pp.57-99. RAE2008

Dros fy mhlu ar draws fy mhlwyf: golwg newydd ar blu Dafydd ap Gwilym

Huws, B. (2004). Dros fy mhlu ar draws fy mhlwyf: golwg newydd ar blu Dafydd ap Gwilym. Dwned. 10, pp.33-55. RAE2008

Dafydd ap Gwilym.net

Edwards, Huw, et al., Golygiad newydd o 33 o gerddi Dafydd ap Gwilym, a chyfraniad 9,830 o eiriau i'r rhagymadrodd ar 'Y Cyd-destun llenyddol' (2007)

Megiston agathon (Pl. Ap. 38 a) – Sedno życia i filozoficznego wyzwania Sokratesa

We suggest a certain minimal approach to the historical Socrates on the basis of Plato’s Apology. This text makes it possible to reconstruct the authentic charge and the defense line of Socrates, as well as his motivation and the quintessence of his philosophical challenge. The most important thing is what the philosopher says in the face of his death sentence: that the greatest good for a man is to live an examined life focusing on virtues and ethical values. Unfortunately, the preponderance of studies, even the most recent ones, fail to recognize the philosopher’s provocative challenge, whilst it is not only a crucial motif in the Socratic examining (ἐξετάζειν), i.e. testing the interlocutors’ knowledge by means of irony, elenchos and aporia, but also an inspiration for his direct and indirect followers in seeking virtues and the greatest good.

A Local Circuit Model of Learned Straitial and Dopamine Cell Responses under Probabilistic Schedules of Reward

Before choosing, it helps to know both the expected value signaled by a predictive cue and the associated uncertainty that the reward will be forthcoming. Recently, Fiorillo et al. (2003) found the dopamine (DA) neurons of the SNc exhibit sustained responses related to the uncertainty that a cure will be followed by reward, in addition to phasic responses related to reward prediction errors (RPEs). This suggests that cue-dependent anticipations of the timing, magnitude, and uncertainty of rewards are learned and reflected in components of the DA signals broadcast by SNc neurons. What is the minimal local circuit model that can explain such multifaceted reward-related learning? A new computational model shows how learned uncertainty responses emerge robustly on single trial along with phasic RPE responses, such that both types of DA responses exhibit the empirically observed dependence on conditional probability, expected value of reward, and time since onset of the reward-predicting cue. The model includes three major pathways for computing: immediate expected values of cures, timed predictions of reward magnitudes (and RPEs), and the uncertainty associated with these predictions. The first two model pathways refine those previously modeled by Brown et al. (1999). A third, newly modeled, pathway is formed by medium spiny projection neurons (MSPNs) of the matrix compartment of the striatum, whose axons co-release GABA and a neuropeptide, substance P, both at synapses with GABAergic neurons in the SNr and with the dendrites (in SNr) of DA neurons whose somas are in ventral SNc. Co-release enables efficient computation of sustained DA uncertainty responses that are a non-monotonic function of the conditonal probability that a reward will follow the cue. The new model's incorporation of a striatal microcircuit allowed it to reveals that variability in striatal cholinergic transmission can explain observed difference, between monkeys, in the amplitutude of the non-monotonic uncertainty function. Involvement of matriceal MSPNs and striatal cholinergic transmission implpies a relation between uncertainty in the cue-reward contigency and action-selection functions of the basal ganglia. The model synthesizes anatomical, electrophysiological and behavioral data regarding the midbrain DA system in a novel way, by relating the ability to compute uncertainty, in parallel with other aspects of reward contingencies, to the unique distribution of SP inputs in ventral SN.